Cell Cycle Control in Cancer

11:00 DKFZ 
Main Auditorium


Host: C. von Kalle

Biosketch Richard Pestell

Dr. Richard Pestell is a leader in the global cancer community. He has galvanized international teams to fight cancer, has 600 published works, and patents in cancer diagnostics and treatment including light-activated gene therapy. He founded companies (ProstaGene, AAAPhoenix) and Institutes, led cancer not–for-profits and directed two US Cancer Centers (Lombardi Comprehensive Cancer Center, and the Sidney Kimmel Cancer Center at Thomas Jefferson University. He was most recently Executive Vice President Thomas Jefferson University.

Dr. Pestell completed his M.D. and Ph.D. in Australia where he conducted Oncology and Endocrinology training. His MBA was from NYU, Stern School of Business. He conducted research at Harvard University and was Clinical Fellow at Massachusetts General Hospital. He is past President of INCTR (USA), a global not-for-profit working to impact cancer in the developing world and was founding Director of the Delaware Valley Institute for Clinical and Translational Science. He received a number of awards for his cancer research (The Royal Australian College of Physicians Winthrop and Neil Hamilton Fairley awards He is an Elected Fellow, American Association for the Advancement of Science, Fellow of the Royal Society of Medicine, member of the American Society of Clinical Investigators. He was recipient of the Irma T. Hirschl Weil Caulier Career Scientist Award, Diane Belfer Faculty Scholar in Cancer Research, Gragnani endowed Chair, the Pfeiffer Award, the Harrison award, the R.D. Wright medal, Komen Light of Life award, a Doctorus Honoris Causa, the Raine Distinguished Professor, Advance Global Australian Award (biotechnology). 

Dr. Pestell has authored >600 published works. His papers have been published in journals including Cell, Science, Nature Medicine, Molecular Cell and EMBO J.